Pharmacotherapy of childhood pneumonia

Expert Opinion on Pharmacotherapy

Volumn 11, Issue 2, 2010, Pages 225-231

  Nascimento Carvalho, Cristiana M ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Acute respiratory infection; Amoxicillin; Antimicrobials; Beta lactam; Streptococcus pneumoniae; Treatment

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; CEFACLOR; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CLARITHROMYCIN; ERYTHROMYCIN; GENTAMICIN; PENICILLIN G; TOBRAMYCIN; VANCOMYCIN;

AGE DISTRIBUTION; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CHLAMYDIASIS; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; HAEMOPHILUS INFLUENZAE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEDLINE; MINIMUM INHIBITORY CONCENTRATION; PNEUMOCOCCAL INFECTION; REVIEW; TREATMENT DURATION; VIRUS INFECTION;

AMOXICILLIN; AMPICILLIN; ANTI-BACTERIAL AGENTS; CHILD; COMMUNITY-ACQUIRED INFECTIONS; DRUG THERAPY; DRUG THERAPY, COMBINATION; HUMANS; OXYGEN; PNEUMONIA; SEVERITY OF ILLNESS INDEX; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

EID: 76749168458     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656560903433714     Document Type: Review

References (46)

1. Scott JA. The global epidemiology of childhood pneumonia 20years on. Bull World Health Organ 2008;86:494-496
2. Mulholland K. Childhood pneumonia mortality - a permanent global emergency. Lancet 2007;370:285-289
3. Grant JP. The state of the world's children, 1990. UNICEF. Oxford: Oxford University Press; 1990
4. Bryce J, Boschi-Pinto C, Shibuya K, Black RE. WHO estimates of the causes of death in children. Lancet 2005;365:1147-1152
5. Wardlaw T, Salama P, Johansson EW, Mason E. Pneumonia: the leading killer of children. Lancet 2006;368:1048-1050
6. WHO, World Health Organization. Case management of acute respiratory infections in developing countries: report of a working group meeting. Document WHO/RSD/85.15 Rev 1. Geneva: WHO; 1985
7. Marsh DR, Gilroy KE, Van de Weerdt R, et al. Community case management of pneumonia: at a tipping point? Bull World Health Organ 2008;86:381-389
8. Sazawal S, Black RE. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis 2003;3:547-556
9. Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis J 1986;5:247-252
10. Korppi M. Mixed microbial aetiology of community-acquired pneumonia in children. APMIS 2002;110:515-522
11. Rudan I, Boschi-Pinto C, Biloglav Z, et al. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 2008;86:408-416
12. Korppi M. Community-acquired pneumonia in children: issues in optimizing antibacterial treatment. Paediatr Drugs 2003;5:821-832
13. Principi N, Esposito S. Paediatric community-acquired pneumonia: current concept in pharmacological control. Expert Opin Pharmacother 2003;4:761-777
14. Virkki R, Juven T, Rikalainen H, et al. Differentiation of bacterial and viral pneumonia in children. Thorax 2002;57:438-441
15. Jacobs MR. Antimicrobial-resistant streptococcus pneumoniae: trends and management. Expert Rev Anti Infect Ther 2008;6:619-635
16. Peltola V, Ruuskanen O. Respiratory viral infections in developing countries: common, severe, and unrecognized. Clin Infect Dis 2008;46:58-60
17. Nascimento-Carvalho CM. Etiology of childhood community acquired pneumonia and its implications for vaccination. Braz J Infect Dis 2001;5:87-97
18. Ostapchuk M, Roberts DM, Haddy R. Community-acquired pneumonia in infants and children. Am Fam Physician 2004;70:899-908
19. Atkinson M, Lakhanpaul M, Smyth A, et al. Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomized controlled equivalence trial. Thorax 2007;62:1102-1106
20. Chetty K, Thomson AH. Management of community-acquired pneumonia in children. Paediatr Drugs 2007;9:401-411
21. Delport SD, Brisley T. Aetiology and outcome of severe community-acquired pneumonia in children admitted to a paediatric intensive care unit. S Afr Med J 2002;92:907-911
22. Nascimento-Carvalho CM, Rocha H, Santos-Jesus R, Benguigui Y. Childhood pneumonia: clinical aspects associated with hospitalization and death. Braz J Infect Dis 2002;6:22-28
23. WHO: World Health Organization. Integrated Management of Childhood Illness chart booklet. (WC 503.2). Geneva: WHO, 2008. Available from: http://whqlibdoc.who.int/publications/ 2008/9789241597289-eng.pdf [Last accessed 15 January 2009]
24. McIntosh K. Community-acquired pneumonia in children. N Engl J Med 2002;346:429-437
25. Gessner BD, Castrodale L, Soriano-Gabarro M. Aetiologies and risk factors for neonatal sepsis and pneumonia mortality among Alaskan infants. Epidemiol Infect 2005;133:877-881
26. Nascimento-Carvalho CM, Souza-Marques HH. Recommendation of the Brazilian Society of Pediatrics for antibiotic therapy in children and adolescents with community-acquired pneumonia. Pan Am J Public Health 2004;15:380-387
27. Reese RE, Betts RF, Gumustop B. Handbook of antibiotics. 3rd edition. Philadelphia: Lippincott Williams & Wilkins; 2000
28. Shann F, Barker J, Poore P. Clinical signs that predict death in children with severe pneumonia. Pediatr Infect Dis J 1989;8:852-855
29. Kabra SK, Lodha R, Pandey RM. Antibiotics for community acquired pneumonia in children. Cochrane Database Syst Rev 2006;3:CD004874
30. Grant GB, Campbell H, Dowell SF, et al. Recommendations for treatment of childhood non-severe pneumonia. Lancet Infect Dis 2009;9:185-196
31. Haider BA, Saeed MA, Bhutta ZA. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2months to 59months. Cochrane Database Syst Rev 2008;2:CD005976
32. Garau J. Role of beta-lactam agents in the treatment of community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 2005;24:83-99
33. Cardoso MR, Nascimento-Carvalho CM, Ferrero F, et al. Penicillin resistant pneumococcus and risk of treatment failure in pneumonia. Arch Dis Child 2008;93:221-225
34. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement. Wayne, PA: CLSI/NCCLS, 2008
35. Nascimento-Carvalho CM, Ferrero F, Cardoso MR. New breakpoints to define resistance to penicillin among pneumococcal pneumonia strains. J Clin Invest 2008;118(e-letter):1291-1300
36. Aspa J, Rajas O, de Castro FR. Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia. Expert Opin Pharmacother 2008;9:229-241
37. Hale KA, Isaacs D. Antibiotics in childhood pneumonia. Paediatr Respir Rev 2006;7:145-151
38. Dagan R, Syrogjannopoulos G, Ashkenazi S, et al. Parenteral-oral switch in the management of paediatric pneumonia. Drugs 1994;47(suppl 3):43-51
39. Ayieko P, English M. Case management of childhood pneumonia in developing countries. Pediatr Infect Dis J 2008;26:432-440
40. Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group. Clinical efficacy of 3days versus 5days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet 2002;360:835-841
41. Kastner U, Guggenbichler JP. Influence of macrolide antibiotics on promotion of resistance in the oral floral of children. Infection 2001;29:251-256
42. García-Rey C, Aguilar L, Baquero F, et al. Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. J Clin Microbiol 2002;40:159-164
43. Zar HJ, Jeena P, Argent A, et al. Diagnosis and management of community-acquired pneumonia in childhood - South African Thoracic Society Guidelines. S Afr Med J 2005;95:977-81,984-990
44. British Thoracic Society of Standards of Care Committee. Acquired pneumonia in childhood BTS guidelines for the management of community. Thorax 2002;57:i1-24
45. Jadavji T, Law B, Lebel MH, et al. A practical guide for the diagnosis and treatment of pediatric pneumonia. Can Med Assoc J 1997;156(Suppl):S703-11
46. American Academy of Pediatrics. In: Pickering LK, Baker CJ, Long SS, McMillan JA, editors, Red Book: 2006 Report of the Committee on Infectious Diseases. 27th edition. Elk Grove Village, IL: American Academy of Pediatrics; 2006